[1]
Areeba Imtiaz et al. 2024. DISRUPTING FIBROGENIC PATHWAYS: INSILICO AND INVITRO EVALUATION OF KAEMPFEROL AND COUMESTROL AS POTENTIAL ANTI-FIBROTIC AGENTS. Journal of Population Therapeutics and Clinical Pharmacology. 31, 9 (Sep. 2024), 4472–4487. DOI:https://doi.org/10.53555/5da3gn95.